Implantable cardioverter defibrillator usage in the commonwealth of Massachusetts – A 10 year study (1998-2008)
Norman S. Kato, M.D., Matthew J. Cioffi, M.S., Sharon-Lise T. Normand, Ph.D. Presented at the American Heart Association Scientific Sessions 2010. There has been a rapid increase in internal cardioverter defibrillator (ICD) use for primary and secondary prevention since FDA approval in 1988. We tested the hypothesis that utilization frequency of ICDs differs by sex in the Commonwealth of Massachusetts.
Hospital-quality Following Percutaneous Coronary Intervention: Massachusetts Experience From 2003-2007.
Normand S-LT, Silbaugh TS, Zelevinsky K, Wolf RE, Cioffi M, Lovett A, Resnic FS, Ho KK. Presented at the American College of Cardiology Scientific Sessions, 2010. Little information is available on hospital performance following percutaneous coronary intervention (PCI) using all-comer populations. Using a fully Bayesian approach, Massachusetts has publicly reported all-cause in-hospital mortality (IHM) following PCI procedures performed since 04/01/2003 in all non-federal hospitals. Key clinical factors, including shock, status of PCI, and compassionate use require adjudication. A small number of risk factors have excellent discrimination of in-hospital survivors at the patient level. Estimates of between-hospital variation can be used to quantify performance at the hospital level.